The Hippo pathway terminal effector TAZ/WWTR1 mediates oxaliplatin sensitivity in p53 proficient colon cancer cells.

Slaninova V, Heron-Milhavet L, Robin M, Jeanson L, Aissanou A, Kantar D, Tosi D, Brehelin L, Gongora C, Djiane A
BMC Cancer. 2024 May 14;24(1):587. doi: 10.1186/s12885-024-12316-4. PubMed Article

Plasmids from Article

No plasmids are currently publicly available from Addgene for this article.